A new study has uncovered how a surprising player in the immune system, eosinophils, best known for their role in allergies ...

New research shows that eosinophils, immune cells usually linked to allergies, also play a protective role against Candida ...

The phase 3 EXHALE-4 study demonstrated that dexpramipexole, an oral small molecule therapy, significantly improved ...

Discover how glucocorticoid-mediated eosinopoiesis in asthma creates a paradox, influencing relapse, steroid resistance, and ...

In a review of seven studies with 567 patients, the four-food elimination diet -- which cuts milk, wheat, eggs, and ...

Positive Results from Clinical Pharmacokinetic Study for the Eosinophilic Esophagitis Specific Formulation with the Drug Candidate AQ280Aqilion today announces positive results from the ARIA-2 ...

The main market opportunities in the eosinophilic esophagitis pipeline include focusing on novel therapeutic approaches, potential development of first-in-class treatments like IRL201104, targeting ...

GSK now has the global development and commercialisation rights to the COPD-targeting oligonucleotide, EMP-012.

Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...

Mepolizumab significantly reduced healthcare resource utilization, including hospitalizations and emergency department visits, in patients with severe eosinophilic asthma over two years. The treatment ...

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...